Could weight-loss drugs like Ozempic help treat alcohol addiction? 

A new review from Lara Ray at UCLA surveys the evidence, and it's genuinely promising. 

Semaglutide, the GLP-1 drug best known for diabetes & weight loss, has shown medium-to-large effects in clinical trials for alcohol use disorder, reducing both drinking & craving. It's one of several novel compounds that could finally move the needle on alcohol treatments. A great example of how a drug developed for one purpose can open up entirely new territory for treating addiction. 

Read the entire paper: Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials